Is Xortx Therapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: XRTX) stock is to Strong Buy XRTX stock.
Out of 1 analyst, 1 (100%) are recommending XRTX as a Strong Buy, 0 (0%) are recommending XRTX as a Buy, 0 (0%) are recommending XRTX as a Hold, 0 (0%) are recommending XRTX as a Sell, and 0 (0%) are recommending XRTX as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year XRTX price target, the average XRTX price target is $14.00, with the highest XRTX stock price forecast at $14.00 and the lowest XRTX stock price forecast at $14.00.
The Wall Street analyst predicted that Xortx Therapeutics's share price could reach $14.00 by Jan 4, 2025. The average Xortx Therapeutics stock price prediction forecasts a potential upside of 440.54% from the current XRTX share price of $2.59.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.